Quality of life (QoL) is one of the most commonly used self-assessment outcome measures in chronic disease. The prison environment has specific characteristics that may affect antiretroviral treatment and adherence in HIV-positive patients. The objective of this cross-sectional study was to analyse the association between several factors and QoL in inmates on antiretroviral treatment in three Andalusian prisons. A total of 160 patients on antiretroviral treatment was enrolled. QoL was measured by means of the MOS-HIV. Of the sample, 88% were men and, of these, 53.8% were considered adherent to treatment. In the multivariate analysis, inmates who were considered adherent, who had a higher educational level, who did not receive food supplements and who were prescribed a greater number of pills were found to have a better physical and mental QoL. Likewise, those who felt unable or scarcely able to continue the treatment and who had been drug abusers for a longer time presented a lower physical QoL. Regarding mental QoL, those without a fixed abode, with difficulties in treatment or chronic disease had lower scores.
Introduction
The global state of health of a patient is a unipersonal concept and, since it is changeable and is measured with a varying degree of subjectivity, it does not always coincide with the doctor's opinion of the severity of a patient's illness (Martínez-González et al., 2000) . One of the most commonly used selfassessment outcome measures in chronic disease is 'health-related QOL' (HRQOL; Badia et al., 1999a) since it provides more precise information that is more sensitive to disease changes and therefore helps to optimise patient care (Remor, 2003) . Antiretroviral therapy plays a double role: on the one hand, it improves the wellbeing of HIV-positive patients and, on the other hand, it often has severe side effects that can have a negative impact on their QoL (Badia et al., 1999a) .
Out of the prison environment, many studies have been conducted on QoL related to HIV-positive patients. Literature shows that patients who adhere to antiretroviral treatment enjoy a higher QoL and that the type, regime and number of prescribed tablets to be taken every day influences the patient's perception of his/her QoL (Douaihy & Singh, 2001; Gill et al., 2002; Low-Beer et al., 2000; Murri et al., 1997; Nieuwkerk et al., 2000; Revicki et al., 1999; Swindells et al., 1999; Wu et al., 1997a) . With regard to the variables that affect the disease itself, lower QoL has been related to high viral load levels, a more advanced stage of AIDS, disease severity, hospital admissions, lower levels of CD4 and the presence of symptoms (Bing et al., 2000; Call et al., 2000; Douaihy & Singh, 2001; Globe et al., 1999 , Nieuwkerk et al., 2000 Short-Posner et al., 2000; Weinfurt et al., 2000) . Likewise, depression, lack of social support, women, older age groups, unemployment and a lower income have also been related to a lower HRQOL (Burgoyne & Renwick, 2004; Douaihy & Singh, 2001; Murri et al., 1997; Swindells et al., 1999; Te Vaarwerk & Gaal, 2001; Tostes et al., 2004) .
However, the prison environment has specific characteristics that may affect antiretroviral treatment and adherence in HIV-positive patients. As described in adherence to antiretroviral drugs, there are characteristics that are exclusive to this environment, such as flexibility of cell opening, which may pose a barrier to correct adherence for inmates (Soto et al., 2005) .
In this respect, few studies have been conducted on QoL in prisons. One study, carried out in Hong Kong, studied HRQOL and its impact on oral health (McGrath, 2002) . Another, conducted on Irish women prisoners (Mooney et al., 2002) , found that prisoners who were drug abusers had a lower QoL.
The aim of this study is to analyse the association between a wide group of clinical, social, psychological and prison environment factors and the physical and mental QoL of inmates on antiretroviral drug therapy in three Andalusian prisons.
Methods
In 2003, a cross-sectional study was performed on inmates treated with antiretrovirals at three prisons in the Autonomous Community of Andalusia. There were a total of 4,315 inmates in all three prisons. Of these, 712 were HIV-positive and 349 had been on antiretroviral treatment. Fifty-three of these inmates had abandoned treatment, giving a total of 296 inmates on antiretroviral treatment.
One hundred and seventy patients were required in order to detect differences of 25% in QoL measurements, a power (1-b) of 85% and confidence level of 95%. Information was obtained from 160 patients.
The response to the QoL variable was considered, using the self-administered MOS-HIV questionnaire, which was developed from the Medical Outcomes Study (MOS; Tarlov et al., 1989; Wu et al., 1997b) . It consists of 35 items grouped in 11 dimensions, which in turn are grouped into two concepts: physical health score (PHS) and mental health score (MHS). It takes 10 Á15 minutes to complete and the Spanish version has been shown to have sufficient reliability and validity to be used in clinical investigation. Reliability value was 70% (Badia et al., 1999b) .
The following independent variables were included: The measurement tool used to collect information was an interview-structured questionnaire, divided into two blocks that grouped the variables mentioned above: block A *socio-demographic, prison environment, drug abuse variables; and block B * variables related to antiretroviral therapy, social support and health. The items in these blocks were taken from previous studies (Olry de Labry et al., 2003; Soto et al., 2005) .
In order to assess antiretroviral treatment adherence, the simplified medication adherence questionnaire (SMAQ) questionnaire (validated in Spain) was used, which consists of six questions and shows 72% sensitivity and 91% specificity. The SMAQ considered that a patient was 'non-adherent' when there was a positive response to any of the qualitative questions (Knobel et al., 2002) .
The sample was distributed homogeneously in each prison and simple randomised sampling was used for selection. Interviews were organised by the medical team at each prison. The inmates had to sign an informed consent, in accordance with Article 8.1 of the prison law. Likewise, confidentiality of data was guaranteed. Questionnaires were administered by trained interviewers who were external to the prison.
CD4 values (cell/mm 3 ) and viral load values (log number of RNA copies/ml) were obtained from computerised clinical records. Access to this data was permitted as a result of collaboration from the prison medical departments and with the prior authorisation of the technical team of the prison centre general directorate.
The flow cytometry test was used to measure CD4 and positive results were confirmed using the Western-Blot test. The Organon Teknika (Boxtel, Holland) NASBA VIH-1 RNA QT NASBA technique was used to measure viral load. The detection threshold of this assay was 50 copies/ml (i.e. 1.69 log 10 copies ml).
With regard to the statistical analysis, first, a description was made of the sample profile and QoL using frequencies, percentages, means and standard deviations. Moreover, the normal distribution of QoL was verified. Second, an analysis was made of any differences in variables for physical and mental QoL from the MOS, using the independent variables. Scores obtained in the HRQOL for each dimension were standardised in order to be able to draw comparisons between scales with different response formats, with scores ranging from 0 Á100, where the highest score represented the highest QoL (Badia et al., 1999a (Badia et al., , 1999b Wu et al., 1997) . For independent qualitative variables with normal performance and homogeneity of variance, Student's t -test and the Anova table were used and, for the other variables, the Mann-Whitney U-test and Kruskal-Wallys H-test were used. For continuous independent variables, linear regression was used. Finally, forward linear regression models were constructed with the independent variables that were shown to be associated at a statistically significant level to physical and mental QoL variables. Moreover, linearity of the models was verified using eigenvalue. All tests were performed with the SPSS v.11.5. statistical package.
Results
A total of 160 patients were studied (94.11% response rate). Of these, 88.7% were men, with a mean sample age of 35.69 years. Over half (53.1%) had not completed primary school education and 7.5% were of no fixed abode. Mean length of sentence of inmates was 93.18 months (7.7 years) and they had an average 37.32 months (3.1 years) still to serve. Theft was the biggest cause of imprisonment (72.5%), followed by public health offence (18.1%) and 64.4% had a specific job in prison. Food quality was graded as poor by 90.8% of inmates, 26.9% said they received supplements and 30.3% said there was flexibility in opening their cells if they had forgotten their medication. Average length of time of drug abuse in the sample studied was 66.3 months (5.5 years) (Table I ). Table I also shows the association between sociodemographic, prison environment and drug abuse variables and QoL. It was observed that those who said they had spent less time abusing drugs and those who did not receive supplements, showed a higher QoL in both physical and mental scores. Furthermore, inmates with fixed abode and a higher level of studies showed a higher mental QoL.
With regard to characteristics related to antiretroviral therapy, social support and health, it was found that 46.3% were considered non-adherent and only 7.6% did not trust the treatment; 30.4% complained of medication problems and 85.4% felt very able to continue the therapy. An average number of 8.67 pills were prescribed per day, only 2.5% said that they had not received an explanation about their treatment from their doctor and 53.1% said that they did not receive necessary medical help. Of inmates questioned, 47.5% said that they received social support in prison and 65% received visits, of which 83.6% were from family members. Forty-five per cent said they had suffered anxiety and/or depression during the last week, 55.3% said they had a chronic disease and 44.4% affirmed that they felt better than one year ago. The mean CD4 and viral load was 401.91 and 4.45, respectively, and 48.5% did not show a detectable viral load (Table II) .
With reference to the HRQOL, the following inmates showed a higher mental QoL: those who were considered as adherent to the antiretroviral treatment, those who felt very able to continue the therapy, those who said they had no problems with the antiretrovirals and those who affirmed that they felt better than one year ago. With regard to the physical QoL score, the highest scores were registered by those who said that they had received an explanation about treatment, those who received visits from their partner/children/friends, those who did not suffer anxiety and/or depression, those who were prescribed a higher number of pills per day and those who were considered as adherent to treatment.
The mean global PHS was 50 (29.49 Á69.02) and the mean global MHS was 50 (17.30 Á65.91). The mean, deviation and ranges obtained for each of the 11 dimensions of the MOS-HIV are shown in Table  III ).
In the multivariate lineal regression analysis, a model was found that explained 25.4% of the variability in physical QoL. A higher physical QoL was associated with having achieved a higher level of study, receiving supplements, feeling very able to continue treatment, taking a greater number of antiretrovirals per day, adhering to treatment and having spent a shorter time abusing drugs.
With regard to mental QoL, a model was found that explained 21.7% of variability. A higher mental QoL was associated independently with receiving supplements, having achieved a higher level of study, no problems with taking antiretroviral drugs, adhering to antiretroviral treatment, absence of any other chronic disease, taking a greater number of antiretrovirals per day and having a fixed abode (Table  IV) .
Discussion
The QoL scores (PHS and MHS) in the MOS-HIV in this sample of inmates are similar to those registered in a non-prison environment Delate & Coons, 2001; Dreher, 2003; Krentz & Gill, 2003; Weinfurt et al., 2000) . With regard to the dimensions, it should be noted that the mean scores of eight of these dimensions fall within the range of findings in literature on non-prison populations. However, the mean scores obtained in mental health, QoL and particularly in general health perception are below those found in literature (57.1 Á69.9 for mental health; 53.9 Á68.2 for QoL and 38.5 Á64.7 for general health perception) (Badia et al., 1999a; Campsmith et al., 2003; Murri et al., 1997; Revicki et al., 1999; Ruiz et al., 2003) .
One method of interpreting the scores obtained in this study is to compare them with HRQOL population standards . In Spain, studies have been carried out on the general population using only generic instruments such as the SF-36 Health Questionnaire. The mean scores for each dimension of this questionnaire in the Spanish population varied from 90.1 in the social function to 66.9 in vitality (Alonso et al., 1998) . Using a different instrument, the mean scores obtained in this study are lower in various dimensions.
Inmates with a higher level of studies presented a higher QoL, which is also found in the non-prison environment (Campsmith et al., 2003; Swindells et al., 1999) . As a general rule and as in the non-prison environment, having achieved a higher level of study can lead to more favourable social circumstances that may logically have a positive impact on QoL.
As in other studies (Swindells et al., 1999) , patients who were considered as adherent showed higher QoL scores. This finding is consistent with other studies that report that the continuous use of one treatment leads to improvement in all MOS-HIV dimensions (Carrieri, 2003; Fleming et al., 2004; Krentz & Gill, 2003; Zinkernagel et al., 2001 ). This has significant clinical implications, since the implementation of strategies to improve adherence in prisons may improve inmates' QoL. However, given the study design, we cannot exclude the hypothesis that a better QoL may improve the antiretroviral adherence. Self-efficiency and selfconfrontation attitudes to continuing treatment are related to improved mental and physical QOL, respectively. This result again shows the importance of psycho-social factors in QoL (Lubeck et al., 1993; Penedo et al., 2003) .
Also, those who were prescribed a greater number of antiretrovirals per day presented a higher QoL, unlike findings in other studies (Murri et al., 1997 ).
However, it should be pointed out that higher levels of CD4 and lower levels of viral load (data not presented) were indicators associated with a higher QoL in the literature (Campsmith et al., 2003; Murri et al., 2003; Short-Posner et al., 2000; Weinfurt et al., 2000) . In this study, however, this association between CD4 and viral load and HRQOL was not found, possibly as the result of the limitations of cross-sectional studies, where (Douaihy et al., 2001) . The fact that inmates who did not receive supplements had a higher QoL may be explained by the environment in which this study was conducted. In prisons, supplements are prescribed by the doctor for nutritional deficiency (low levels of albumin, prealbumin and transferrin) and these supplements may be related to a lower health-related QoL. Finally, although the variability explained by the models was low, it should be taken into account that the objective of this study was not to find a predictive model of QoL.
Conclusion
This study shows that QoL in prison is affected by a group of psycho-social factors in a similar way to QoL in a non-prison environment. Doctors' acknowledgement of the importance of these factors may contribute to the development of strategies to improve the QoL of these patients. In the prison environment, the relationship between antiretroviral adherence and QoL is again noted. For this reason, efforts should be focused on increasing and/or maintaining antiretroviral adherence in this population, increasing self-efficiency and self-confrontation to continue treatment, which may serve to improve health and QoL of prison inmates. Physicians should recognise QoL and treatment adherence as major objectives of HIV treatment in prison.
